We have crossed 150 peeps so on to a second starter pack
go.bsky.app/N27Kzri
Join now and ping me to get added and dive into the #NephSky community rightaway
1/10
Did you miss last week’s #NephJC chat?
Too busy fretting over politics?
No worries, the #TenTweetNephJC will get you all caught-up on Long-term Effects of #Empagliflozin in patients with #CKD
10/10
Final #nephjc thoughts
✳️ The 🔑 takeaway from this study is straightforward 👉 initiate #SGLT2i early, ensure consistent therapy, & recognize that the protective effects are not sustained after discontinuation.
Flozinate early and persist with flozination.
Monotypic fibrillary glomerulonephritis is not a MGRS in the vast majority of cases.
In cases with monotypic fibrillary - do IgG subclasses, do par IF, and check SPEP/UPEP for evaluation of true clonality.
Insights from @VBijol and @MayoClinicPath at @GlomCon
Holy shit this is INCREDIBLE work from @ByDonkeys. And bonus points for projecting the entire thing on @Tesla headquarters, effectively turning @elonmusk’s building’s most visible exterior side into a cinema screen to broadcast the tale of his corruption and political malfeasance
Interesting viewpoint from @jingelfinger
Way Stations in Progress — Burgeoning Treatment Options for IgA Nephropathy | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…
#NephJC proteinuria is a surrogate of a surrogate (eg. eGFR decline) which is itself a surrogate of clinical kidney failure…& there is no surrogate for safety. Our community must prioritise large trials wherever we can…our patients deserve better!
#NephJC underuse of #SGLT2i reasons seem to be multiple: too late to treat (low eGFR), perhaps some ongoing uncertainty, some lack of reimbursement and definitely some missed opportunity….slide to help explain below
We are delighted to announce the full programme for our online conference taking place next week November 6th: Rare Rheumatology, Niche Conditions and Future Directions. Registration is still open via the link below:
forms.gle/ESaZCqRTDJJQMcuf7
1b/ Today, we will discuss a study by Li, J., et.al. that explores this potential biomarker❗
Read the study here ➡️ kireports.org/article/S2468-…
Beautiful visual abstract 🤩 by @NephroSeeker